
ALBOR BIOTECH
Preclinical CRO for metabolic disorders
Albor Biotech is a Preclinical Contract Research Organization (CRO) specializes in meticulously evaluating the drug development process from early screening.

About us

Capabilities

Publications

News

Contact us

CRO Services
Your partner for efficacy and validation studies
Our aim is to assist pharmaceutical, biotechnology and nutraceutical companies, along with research laboratories, in optimizing preclinical drug candidate studies. By doing so, we endeavor to significantly decrease both the cost and time to market for new therapies. Over a span exceeding 15 years, we have been developing and using our expertise in metabolic diseases and behavior mechanisms, leveraging it to deliver reliable preclinical studies targeting a spectrum of pathologies, such as obesity, diabetes, NASH/MASH fibrosis, inflammation, oxidative stress, and conditions influencing behavior. In this way, we carry out a wide range of tests to demonstrate the effectiveness of our clients’ drug candidates.
Different services
Years of experience
Our Values
About us
Who We Are
We are a Contract Research Organization (CRO) specializing in preclinical studies, offering tailored solutions for biotech and pharmaceutical companies. With a multidisciplinary team of experts in molecular biology, pharmacology, and bioinformatics, we provide high-quality, reliable, and efficient services to support the development of new therapies.
Our Expertise
Our core expertise lies in preclinical research, encompassing in vitro and in vivo studies, biomarker discovery, and toxicology assessments. By leveraging state-of-the-art technologies and rigorous scientific methodologies, we help our clients optimize their drug development pipelines and navigate regulatory requirements with confidence.